| Identification | Back Directory | [Name]
3-BenzofurancarboxaMide, 2-(4-fluorophenyl)-N-Methyl-5-(1-Methylethoxy)-6-[(Methylsulfonyl)aMino]- | [CAS]
691852-36-5 | [Synonyms]
HCV086
HCV-086
HCV 086
2-(4-fluorophenyl)-6-(methanesulfonamido)-N-methyl-5-propan-2-yloxy-1-benzofuran-3-carboxamide
3-BenzofurancarboxaMide, 2-(4-fluorophenyl)-N-Methyl-5-(1-Methylethoxy)-6-[(Methylsulfonyl)aMino]- | [Molecular Formula]
C20H21FN2O5S | [MDL Number]
MFCD18206778 | [MOL File]
691852-36-5.mol | [Molecular Weight]
420.45 |
| Hazard Information | Back Directory | [Description]
HCV-086 is a RNA-directed RNA polymerase (NS5B) inhibitor for the treatment of HCV infection. | [Uses]
HCV-796 analog is a potent NS5B inhibitor that binds to the palm II site. HCV-796 analog is promising for research of hepatitis C (HCV) infections[1]. | [References]
[1] McComas CC, et al. Development of a New Structural Class of Broadly Acting HCV Non-Nucleoside Inhibitors Leading to the Discovery of MK-8876. ChemMedChem. 2017 Sep 7;12(17):1436-1448. DOI:10.1002/cmdc.201700228 |
|
|